Literature DB >> 1484932

Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study.

R Ramakrishna1, K Chaudhuri, A Sturgess, A Manoharan.   

Abstract

Clinically significant cytopenias are thought to be uncommon in primary Sjögren's syndrome: only a few cases have been reported in the literature. Over a 3-year period we identified haematological abnormalities in 11 of 27 patients with Sjögren's syndrome. Six patients had a positive direct antiglobulin test, including one patient with all the features of autoimmune haemolytic anaemia and two others with some features of this condition. Four patients had immune thrombocytopenia and two patients had myelodysplastic syndrome. Neutropenia was noted in two patients, one patient had aplastic anaemia and one had pure red cell aplasia. Haematological disorders were found to be common in patients with Sjögren's syndrome (40 per cent). Accordingly, we suggest that patients with immune cytopenia(s) should be screened for Sjögren's syndrome using sensitive assays for anti-SS.A and anti-SS.B antibodies, and that patients with Sjögren's syndrome should be periodically monitored, with a full blood count to rule out any haematological abnormality.

Entities:  

Mesh:

Year:  1992        PMID: 1484932

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.

Authors:  Bum-Su Choung; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-03-17       Impact factor: 2.631

2.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

Review 3.  [Rheumatic and hemato-/oncological disorders].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

4.  Thrombocytopenia caused by albendazole in a patient with Sjögren's syndrome: A case report.

Authors:  Pınar Açıkgöz; İbrahim Halil Türkbeyler; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2014-03-01

5.  Primary Sjögren's syndrome in men.

Authors:  J M Anaya; G T Liu; E D'Souza; N Ogawa; X Luan; N Talal
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

6.  Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.

Authors:  Bradley T Williamson; Lynda Foltz; Heather A Leitch
Journal:  Hematol Rep       Date:  2016-05-10

7.  Elevated CCL19/CCR7 Expression During the Disease Process of Primary Sjögren's Syndrome.

Authors:  Zhenwei Liu; Fengxia Li; Axiao Pan; Huangqi Xue; Shan Jiang; Chengwei Zhu; Mengmeng Jin; Jinxia Fang; Xiaochun Zhu; Matthew A Brown; Xiaobing Wang
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

8.  Clinical and laboratory features of primary Sjögren's syndrome complicated with mild to severe thrombocytopenia.

Authors:  Jian Wu; Xin Chang; Jian Zhang; Cuiping Liu; Mingxing Liu; Weichang Chen
Journal:  Ann Transl Med       Date:  2022-03

9.  Primary Sjogren's syndrome presenting as autoimmune cytopenia.

Authors:  Durga Shankar Meena; Gopal Krishana Bohra
Journal:  Clin Pract       Date:  2019-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.